Home
Conditions
Histiocytosis

Clinical trial condition

Histiocytosis

Explore clinical trials studying Histiocytosis. Study availability and eligibility vary by location and protocol.

406 public trials 82 recruiting studies

Refine in advanced search Browse all conditions

Histiocytosis trial results

Recruiting

Real-World Study of DLBCL With Different Genetic Subtypes

NCT06026488

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +9 more
Locations: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Establishment of an Early Warning Screening System for Hemophagocytic Lymphohistiocytosis a Multi-center, Prospective Study

NCT06614998

Conditions: Hemic and Lymphatic Diseases, Hemophagocytic Syndrome, Histiocytosis, +3 more
Locations: Affilitated Hospital of Xuzhou Medical University Xuzhou, Jiangsu, China

View Trial Details

Recruiting

Comparison of Point-of-care Produced CAR T-cell with Commercial CAR T-cells in Patients with R/R LBCL

NCT05641428

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +6 more
Locations: NL-Amsterdam-AMC Amsterdam, Netherlands

NL-Groningen-UMCG Groningen, Netherlands

NL-Leiden-LUMC Leiden, Netherlands

NL-Maastricht-MUMC Maastricht, Netherlands

View Trial Details

Recruiting

Flow Cytometry for the Study of T-Cell Populations in Hemophagocytic Lymphohistiocytosis Associated With Lymphomas

NCT06585124

Conditions: Hemic and Lymphatic Diseases, Hemophagocytic Lymphohistiocytoses, Histiocytosis, +9 more
Locations: Stefan Hohaus Rome, Lazio, Italy

View Trial Details

Recruiting

Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study

NCT06534762

Conditions: Breast Diseases, Breast Neoplasms, Carcinoma, +45 more
Locations: Zhejiang Provincial People's Hospital Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict)

NCT06526065

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
Locations: Universitätsmedizin Göttingen Göttingen, Lower Saxony, Germany

View Trial Details

Recruiting

Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL

NCT06287398

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, DLBCL, Nos Genetic Subtypes, Dendritic Cell Sarcoma, Interdigitating, +21 more
Locations: Australasian Leukemia and Lymphoma Group Melbourne, Victoria, Australia

View Trial Details

Recruiting

Biomarkers for Diagnostic, Prognostic and of Response to Treatment in Adult Langerhans Cell Histiocytosis

NCT06197204

Conditions: Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +4 more
Locations: Hopital Saint Louis Paris, France

View Trial Details

Recruiting

Study to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy (PRO-MIND)

NCT06299553

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
Locations: Incyte Biosciences Italy S.r.l Milan, Italy

View Trial Details

Recruiting

Oral Prednisone in Treating LCH of Bone in Childhood and Adolescence

NCT06078969

Conditions: Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
Locations: Shanghai Changzheng Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Histiocytosis

Histiocytosis trial results

Related conditions